I wouldn't view it as all negative! Multicentre site means broadening of this study, this could play very well for us over the longer term.
- Forums
- ASX - By Stock
- PAR
- Ann: Phase 2 Synovial Fluid Biomarker Study Update
PAR
paradigm biopharmaceuticals limited..
Add to My Watchlist
2.38%
!
41.0¢

Ann: Phase 2 Synovial Fluid Biomarker Study Update, page-5
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
41.0¢ |
Change
-0.010(2.38%) |
Mkt cap ! $162.9M |
Open | High | Low | Value | Volume |
42.0¢ | 42.3¢ | 39.5¢ | $453.0K | 1.114M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 56336 | 41.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
42.0¢ | 70000 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 1961 | 0.430 |
1 | 1398 | 0.420 |
1 | 8441 | 0.415 |
1 | 49348 | 0.410 |
2 | 19000 | 0.400 |
Price($) | Vol. | No. |
---|---|---|
0.395 | 1518 | 1 |
0.400 | 10283 | 2 |
0.415 | 5888 | 1 |
0.420 | 70000 | 2 |
0.425 | 4000 | 1 |
Last trade - 16.10pm 17/07/2025 (20 minute delay) ? |
Featured News
PAR (ASX) Chart |
The Watchlist
LU7
LITHIUM UNIVERSE LIMITED
Iggy Tan, Executive Chairman
Iggy Tan
Executive Chairman
SPONSORED BY The Market Online